Meanwhile, overexpression of HSPA2 was related to tumor angiogenesis and poor prognosis of pancreatic cancer, while the survival prognosis of breast cancer patients with high expression of NOX4 was poor, too (Zhai et al., 2017; Ham et al., 2018). The gene discussed is HSPA2; the disease is breast carcinoma.